Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Male Urogenital Diseases × CP protocol × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urologic Neoplasms 1 Urogenital Neoplasms 1 Penile Neoplasms 1 Male Urogenital Diseases 1

Interventions

padeliporfin 4 Lycopene 3 darolutamide 2 Vitamin E 2 Tea 2 Selenium 2 Cholecalciferol 2 pembrolizumab 1 palladium-bacteriopheophorbide 1 olaparib 1 gedatolisib 1 Therapeutics 1 Sugars 1 Pluvicto 1 Intraoperative Neurophysiological Monitoring 1 CP protocol 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06353906 2025-12-08

PRIAM

The Netherlands Cancer Institute

Phase 2 Recruiting

Penile Neoplasms, Urogenital Neoplasms, Urologic Neoplasms, Male Urogenital Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡